Bridgewater Associates LP Trims Stock Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Bridgewater Associates LP trimmed its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 43.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 32,019 shares of the company's stock after selling 24,558 shares during the quarter. Bridgewater Associates LP's holdings in GE HealthCare Technologies were worth $2,503,000 at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. CoreFirst Bank & Trust acquired a new position in shares of GE HealthCare Technologies during the fourth quarter worth $25,000. Runnymede Capital Advisors Inc. acquired a new position in shares of GE HealthCare Technologies during the fourth quarter valued at about $28,000. Bank of Jackson Hole Trust bought a new position in GE HealthCare Technologies in the 4th quarter valued at about $32,000. Flagship Wealth Advisors LLC acquired a new position in GE HealthCare Technologies during the 4th quarter valued at about $34,000. Finally, OFI Invest Asset Management bought a new stake in GE HealthCare Technologies during the 4th quarter worth approximately $34,000. 82.06% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on the company. BTIG Research set a $95.00 target price on GE HealthCare Technologies and gave the company a "buy" rating in a research report on Monday, April 14th. The Goldman Sachs Group raised GE HealthCare Technologies from a "neutral" rating to a "buy" rating and lifted their target price for the company from $85.00 to $100.00 in a research report on Tuesday, March 11th. Wells Fargo & Company boosted their price objective on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an "overweight" rating in a research report on Friday, February 14th. Jefferies Financial Group upgraded GE HealthCare Technologies from a "hold" rating to a "buy" rating and lifted their target price for the stock from $95.00 to $103.00 in a research note on Wednesday, January 8th. Finally, Citigroup increased their price target on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the company a "buy" rating in a research report on Thursday, February 13th. One analyst has rated the stock with a sell rating, two have given a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $96.50.

GE HealthCare Technologies Trading Up 1.9 %

GE HealthCare Technologies stock traded up $1.26 during mid-day trading on Thursday, reaching $66.15. 2,477,132 shares of the company traded hands, compared to its average volume of 3,221,939. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 0.83. The firm's 50 day moving average price is $77.57 and its 200 day moving average price is $82.50. The firm has a market capitalization of $30.29 billion, a price-to-earnings ratio of 15.28, a P/E/G ratio of 3.19 and a beta of 1.14. GE HealthCare Technologies Inc. has a 52-week low of $57.65 and a 52-week high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its quarterly earnings results on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.26 by $0.19. The company had revenue of $5.32 billion for the quarter, compared to analysts' expectations of $5.33 billion. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. On average, analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Friday, April 25th will be given a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a dividend yield of 0.21%. The ex-dividend date is Friday, April 25th. GE HealthCare Technologies's payout ratio is currently 3.23%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.